Country: Malaysia
Language: English
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
ECONAZOLE NITRATE; TRIAMCINOLONE
SUNWARD PHARMACEUTICAL SDN. BHD.
ECONAZOLE NITRATE; TRIAMCINOLONE
400 gm; 50x15 gm; 15 gm
SUNWARD PHARMACEUTICAL SDN. BHD.
NOT APPLICABLE Read the complete document
TRICONAZOLE CREAM Composition: Triamcinolone Acetonide BP 0.1% w/w Econazole Nitrate BP 1.0% w/w PHARMACOLOGY: Triamcinolone acetonide and econazole nitrate combination has anti-inflammatory, anti-pruritic, anti-fungal and anti-bacterial action. Econazole acts by damaging cell membranes. The permeability of the fungal cell is increased. Subcellular membranes in the cytoplasm are damaged. The site action is most probably the unsaturated fatty acid acyl moiety of membrane phospholipids. Triamcinolone acetonide is a more potent form of the naturally occurring adrenocorticol hormone. The mechanism of anti-inflammatory activity of the corticosteroids is unclear, but there is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. When applied topically, particularly to large areas, the triamcinolone acetonide may be absorbed in sufficient amount to cause systemic effect. It is slowly metabolized in the skin and thus tend to be systemically absorbed to a greater extend. After topical application to the skin of normal subjects, systemic absorption of econazole nitrate in extremely low. Although most of the applied drug remains on the skin surface, drug concentrations were found in the stratum corneum which, by far, exceeded the minimum inhibitory concentration for dermatophytes. Inhibitory concentrations are achieved in the epidermis and as deep as the middle region of the dermis. Less than 1% of the applied dose was recovered in the urine and faeces. INDICATIONS: Inflammatory dermatoses with mycotic or bacterial infection. Inflammatory dermatomycoses caused by dermatophytes, yeasts and molds. CONTRAINDICATIONS: It is contraindicated in patient who are hypersensitive to econazole nitrate, triamcinolone or other corticosteriods. WARNING AND PRECAUTIONS: The medication should be discontinued if irritation occurred. Do not use in and around eyes. Special precaution should be taken when medication is used in children. USE IN PREGNANCY AND LACTATION: Read the complete document